Mimedx (MDXG) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Mimedx (MDXG) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 29.47% |
| 10 | Mimedx | 639.06 Mn | 479.29 Mn | 41.62 Mn | -454.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -454.50% |
| Dec 31, 2025 | 68.10% |
| Sep 30, 2025 | 90.55% |
| Jun 30, 2025 | 60.34% |
| Mar 31, 2025 | 54.07% |
| Dec 31, 2024 | -148.82% |
| Sep 30, 2024 | 101.95% |
| Jun 30, 2024 | 143.62% |
| Mar 31, 2024 | 42.40% |
| Dec 31, 2023 | -27.93% |
| Sep 30, 2023 | 22.53% |
| Jun 30, 2023 | 62.94% |
| Mar 31, 2023 | 68.47% |
| Dec 31, 2022 | 24.78% |
| Sep 30, 2022 | -46.69% |
| Jun 30, 2022 | 40.31% |
| Mar 31, 2022 | 2.50% |
| Dec 31, 2021 | 26.25% |
| Sep 30, 2021 | -27.69% |
| Mar 31, 2021 | -27.70% |